Rating of Included Trials on the Efficacy–Effectiveness Spectrum: development of a new tool for systematic reviews

L. Susan Wieland; Brian Berman; Douglas G. Altman; Jürgen Barth; L.M. Bouter; Christopher R. D’Adamo; Klaus Linde; David Moher; C. Daniel Mullins; Shaun Treweek; Sean Tunis; Daniëlle van der Windt; Merrick Zwarenstein; Claudia M. Witt

doi:10.1016/j.jclinepi.2017.01.010

Back

Rating of Included Trials on the Efficacy–Effectiveness Spectrum: development of a new tool for systematic reviews

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2007

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

Beverley Shea, Jeremy Grimshaw, George A. Wells, Maarten Boers, Neil Andersson, Candyce Hamel, Ashley C Porter, Peter Tugwell, David Moher, L.M. Bouter

Article2020

A Systematic Review of Randomised Controlled Trials on the Effectiveness of Ecotherapy Interventions for Treating Mental Disorders

Taryn Williams, Garret Barnwell, Dan Joseph Stein

Article2021

Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt, Isabelle Boutron, Tammy Hoffmann, Cynthia D. Mulrow, Larissa Shamseer, Jennifer Tetzlaff, David Moher

Preprint2020

Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt, Isabelle Boutron, Tammy Hoffmann, Cynthia D. Mulrow, Larissa Shamseer, Jennifer Tetzlaff, David Moher

Article2013

Assessing Risk of Bias in Randomised Clinical Trials Included in Cochrane Reviews: The why is Easy, the how is a Challenge

Asbjørn Hróbjartsson, Isabelle Boutron, Lucy Turner, Douglas G. Altman, David Moher